Search company, investor...
Search

Founded Year

2017

Stage

Series B | Alive

Total Raised

$185.2M

Last Raised

$150M | 10 mos ago

Mosaic Score

+40 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Iterative Scopes

Iterative Scopes is a software-only gastrointestinal data company that is working to deliver AI toolkits to the practice of gastroenterology.

Iterative Scopes Headquarters Location

14 Arrow St 3rd Floor

Cambridge, Massachusetts, 02138,

United States

267-616-5397

ESPs containing Iterative Scopes

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Healthcare Providers Tech

Companies in this market provide software and hardware to provide real-time surgical guidance and workflow automation. These solutions are designed to improve the accuracy, efficiency, and reproducibility of surgeon performance, by creating systemic methods for process improvement and quality control in surgery.

Iterative Scopes named as Leader among 14 other companies, including Caresyntax, Theator, and ACTIV Surgical.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Iterative Scopes's Products & Differentiation

See Iterative Scopes's products and how their products differentiate from alternatives and competitors

  • AI Recruitment service

    The AI Recruitment service is designed to help clinical research teams and pharmaceutical companies accelerate their IBD clinical trials through a combination of cutting-edge proprietary AI-driven algorithms and computer vision advances.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing Iterative Scopes

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Iterative Scopes in 2 CB Insights research briefs, most recently on Aug 9, 2022.

Expert Collections containing Iterative Scopes

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Iterative Scopes is included in 7 Expert Collections, including Digital Health.

D

Digital Health

21,952 items

Startups recreating how healthcare is delivered

A

Artificial Intelligence

9,391 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,732 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

314 items

Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging

D

Digital Health 150

150 items

The winners of the third annual CB Insights Digital Health 150.

H

Health IT

8,264 items

Iterative Scopes Patents

Iterative Scopes has filed 3 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Gastroenterology
  • Gastrointestinal tract disorders
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/22/2021

Autoimmune diseases, Inflammations, Gastrointestinal tract disorders, Gastroenterology, Immune system

Application

Application Date

7/22/2021

Grant Date

Title

Related Topics

Autoimmune diseases, Inflammations, Gastrointestinal tract disorders, Gastroenterology, Immune system

Status

Application

Latest Iterative Scopes News

Shrujal Baxi Named Chief Medical Officer at Iterative Scopes

Sep 28, 2022

Baxi previously worked at Verana Health and Flatiron Health. Michael Barbella, Managing Editor09.28.22 Iterative Scopes  has welcomed Shrujal Baxi, M.D., into its executive fold, appointing her as chief medical officer. Baxi specializes in real-world evidence generation, and throughout her career has been involved in multiple clinical trials. In her role as CMO, she will help develop the company’s scientific roadmap and drive forward its mission of using scalable technology and data to advance inflammatory bowel disease (IBD) care and improve patient outcomes. “Having a stellar scientific, medical, and regulatory affairs team is critical to Iterative Scopes’ work, and we're very excited to have Dr. Baxi leading these groups,” said Jonathan Ng, MBBS, founder and CEO of Iterative Scopes. “As a medical oncologist, Dr. Baxi has witnessed a transformation in oncology that has accelerated the public’s understanding of cancer while also fueling precise management of the disease. Data has driven this innovation and knowledge generation, and I look forward to seeing her apply this expertise to our focus on individualized care for people with inflammatory bowel disease.”    Prior to joining Iterative Scopes, Baxi was senior vice president of Clinical and Scientific Solutions at Verana Health, where she incorporated the voice of the clinician throughout the real-world data (RWD) development process from ingestion through technology-enabled curation and analysis. Before that, she was head of Clinical Science at Flatiron Health, where—using RWD created from electronic health records for regulatory and health-technology-assessment use cases—she focused her time on evidence generation. She also worked with data scientists and engineers to generate high-quality novel datasets. Baxi earned her medical degree from the University of Illinois College of Medicine at Chicago and her master's degree in public health with an emphasis on health policy and administration from the University of Illinois School of Public Health. After serving as a chief resident at New York University, she completed a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center and joined its faculty in 2011, where she specialized in cancers of the head and neck, salivary glands, and thyroid along with non-melanoma cutaneous malignancies. “I look forward to helping Iterative Scopes tell the story of using data with AI technology’s capabilities—and why it all matters,” Baxi said “Iterative Scopes is advancing the science of gastroenterology and facilitating clinical trials in IBD, and this should be shared and celebrated.”   Iterative Scopes applies artificial intelligence-based precision medicine for gastroenterology. Its proprietary artificial intelligence and computer vision technologies have the potential to improve the accuracy and consistency of endoscopy readings. Iterative Scopes is initially applying these advances to impact polyp detection for colorectal cancer screenings and working to standardize disease severity characterization for inflammatory bowel disease. Longer term, the company plans to establish more meaningful endpoints for GI diseases, which may be better predictors of therapeutic response and disease outcomes. Spun out of MIT in 2017, the company is based in Cambridge, Mass. Trending

Iterative Scopes Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Iterative Scopes Rank

  • When was Iterative Scopes founded?

    Iterative Scopes was founded in 2017.

  • Where is Iterative Scopes's headquarters?

    Iterative Scopes's headquarters is located at 14 Arrow St, Cambridge.

  • What is Iterative Scopes's latest funding round?

    Iterative Scopes's latest funding round is Series B.

  • How much did Iterative Scopes raise?

    Iterative Scopes raised a total of $185.2M.

  • Who are the investors of Iterative Scopes?

    Investors of Iterative Scopes include Eli Lilly and Company, Breyer Capital, Obvious Ventures, Johnson & Johnson Innovation, Plug and Play Ventures and 16 more.

  • Who are Iterative Scopes's competitors?

    Competitors of Iterative Scopes include Butterfly Network, Koios Medical, Virgo Surgical Video Solutions, Cleerly, Lunit, Aidoc Medical, Viz.ai, SenseTime, Overjet, Aiforia and 29 more.

  • What products does Iterative Scopes offer?

    Iterative Scopes's products include AI Recruitment service and 1 more.

You May Also Like

Viz.ai Logo
Viz.ai

Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.

RapidAI Logo
RapidAI

RapidAI is using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus.

Perspectum Logo
Perspectum

Perspectum is a provider of digital technologies that help clinicians provide better care for patients with liver disease. The company's work focuses on the detection and accurate, quantitative measurement of liver, gall bladder, and pacreatic disease.

Ultrasight Logo
Ultrasight

Ultrasight develops an automated ultrasound solution that provides AI-based navigation, analysis, and diagnosis at the point of care.

Infervision Logo
Infervision

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

S
Shukun Technology

Shukun Technology develops diagnostic systems by using machine learning and AI technology for hospitals to improve efficiency. The company focuses on cardiovascular diagnosis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.